top of page

Sex-specific proteomic panels enhance SCORE2 cardiovascular risk prediction

  • Writer: Seungjun Yeo
    Seungjun Yeo
  • 5 days ago
  • 0 min read
ROC curves comparing SCORE2 vs SCORE2+proteins for total, male, and female cohorts, showing higher sensitivity with proteomic augmentation.

 
 
logo02_edited.png

California NanoSystems Institute

570 Westwood Plaza
Bldg 114, Rm 6350H, Mail 722710
Los Angeles, California 90095‐7227

Copyright © 2025

Dalton Bioanalytics Inc.

Home

Company

Technology

Application

Analysis Services

Subscribe to Our Newsletter

Thanks for subscribe!

bottom of page